Cadrenal Therapeutics
CVKD
#11070
Rank
โ‚ฌ4.24 M
Marketcap
1,37ย โ‚ฌ
Share price
0.00%
Change (1 day)
-86.38%
Change (1 year)

EPS for Cadrenal Therapeutics (CVKD)

EPS in 2026 (TTM): -4,60ย โ‚ฌ

According to Cadrenal Therapeutics's latest financial reports the company's current EPS (TTM) is -4,87ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -6,03ย โ‚ฌ an increase over its 2024 EPS that were of -7,92ย โ‚ฌ.

EPS history for Cadrenal Therapeutics from 2023 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-4,60ย โ‚ฌ-23.68%
2025-6,03ย โ‚ฌ-23.94%
2024-7,92ย โ‚ฌ-6.03%
2023-8,43ย โ‚ฌ